Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Wayne State University
With
Henry Ford Hospital
St. John Providence Health System
Detroit Medical Center
Forest Laboratories
Age
18–89
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Acute bacterial skin and skin structure infection (cellulitis, major abscess, surgical site infection)
Presence of MRSA or documented risk factors for MRSA (prior antibiotic use 60 days, prior hospital exposure 180 days, skin ulcers, central venous catheter)
Anticipating no less than two days of hospital admission
Signed informed consent
You may not be if
Gas gangrene/progressive necrotizing infections
Osteomyelitis
Infections due to Gram-negative pathogens or other Gram-positive pathogens if S. aureus or Streptococcus is not present
Pathogens known at the study entry to be resistant to ceftaroline or vancomycin
Anticipated to require non-study antibiotic active against S. aureus for another reason
Treatment for the current episode of ABSSSI for \> 24 hours with another intravenous anti-MRSA antibiotic
Surgical (I \& D) as definitive/curative treatment
Presence of prosthetic hardware or invasive devices suspected to be the source of infection but cannot be removed
Life expectancy \< 2 months
Open burn wound \> 30% total body surface area
Pregnant or nursing mothers
Known allergic reaction to vancomycin or ceftaroline
Clareo Health | Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA
